Showing results (1091-1100 of 2,231) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesisChang Hwan Ju, Jae Min Jeong, Yun-Sang Lee, et al.Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Fetal-maternal microchimerism enhances the survival effect of interleukin-2-activated haploidentical peripheral blood stem cell treatment in patients with advanced solid cancerYing Han, Jinpu Yu, Shui Cao, et al.Cancer Biotherapy & Radiopharmaceuticals|October 19, 2010
Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cellsWei-Li Xu, Qi Wang, Ming Du, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Positive progress in immunoPET--not just a coincidenceKatelyn E McCabe, Anna M WuCancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modelingPeter Kletting, Christoph Meyer, Sven N Reske, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
The ultrastructural study of tumorigenic cells using nanobiomarkersLorena Favaro Pavon, Luciana Cavalheiro Marti, Tatiana Tais Sibov, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distributionJohn A Barrett, John L Joyal, Shawn M Hillier, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Relationship between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in incidentally detected thyroid cancerBo Hyun Kim, In Joo Kim, Sang Soo Kim, et al.Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cellsShu Xia, Yin Zhao, Shiying Yu, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2010
Therapeutic use of avidin is not hampered by antiavidin antibodies in humansFiorella Petronzelli, Angela Pelliccia, Anna Maria Anastasi, et al.Pageof 224